7,376.86

+23.13

+0.31%

51,285.73

-237.33

-0.46%

24,579.42

+264.43

+1.09%

2,754.11

+24.22

+0.89%

4.8590

+0.0220

+0.45%

25.64

-2.54

-9.01%

4,074.90

-38.60

-0.94%

75,910.27

+58.75

+0.08%

Crude Oil Dec 26

90.83

+0.31

+0.34%

US Private Equity

10,772.76

+11.83

+0.11%

Frankfurt - Delayed Quote EUR

Danaher Corporation (DAP.F)

200.40 -4.20 (-2.05%)

At close: November 6 at 2:45:47 PM GMT+1

Loading Chart for DAP.F

Chart Range Bar

Interval:

In partnership with ChartIQ

Are You Overpaying For Abbott Stock Versus Its Rivals?

Are You Overpaying For Abbott Stock Versus Its Rivals?

O2 Investment Partners Announces Appointment of Rob Calice as Senior Director, Portfolio Operations

O2 Investment Partners Announces Appointment of Rob Calice as Senior Director, Portfolio Operations

Danaher (DHR) Stock Fair Value Rises After Higher Analyst Targets And Q3 Commentary

Danaher (DHR) Stock Fair Value Rises After Higher Analyst Targets And Q3 Commentary

Guidance Up, Trend Intact: Mettler-Toledo Is Today's Double-Confirmation Stock

Guidance Up, Trend Intact: Mettler-Toledo Is Today's Double-Confirmation Stock

Danaher (DHR) Wins FDA Clearance For Hemorrhagic Fever Test With Four Virus Detection

Danaher (DHR) Wins FDA Clearance For Hemorrhagic Fever Test With Four Virus Detection

Microcarriers - Global Strategic Business Report 2026: Secure Your Share of $3.9 Billion by 2032 | Benchmark Corning, Danaher, Sartorius, and Thermo Fisher

Microcarriers - Global Strategic Business Report 2026: Secure Your Share of $3.9 Billion by 2032 | Benchmark Corning, Danaher, Sartorius, and Thermo Fisher

Downstream Processing - Global Strategic Business Report 2026: Capitalize on 15.7% CAGR to US$128.9 Billion by 2032 as Danaher, Merck, Sartorius, and Thermo Fisher Reshape Biomanufacturing

Downstream Processing - Global Strategic Business Report 2026: Capitalize on 15.7% CAGR to US$128.9 Billion by 2032 as Danaher, Merck, Sartorius, and Thermo Fisher Reshape Biomanufacturing

Cell Based Assays - Global Strategic Business Report 2026: Capitalize on the $30.5B Market by 2032 as Thermo Fisher, Danaher, Merck KGaA and Lonza Accelerate AI, 3D Cultures and Automation

Cell Based Assays - Global Strategic Business Report 2026: Capitalize on the $30.5B Market by 2032 as Thermo Fisher, Danaher, Merck KGaA and Lonza Accelerate AI, 3D Cultures and Automation

Cell Counting - Global Strategic Business Report 2026: Capitalize on US$6 Billion Growth by 2032 as Abbott, Becton Dickinson, Bio-Rad, Danaher, and Sysmex Drive Automation

Cell Counting - Global Strategic Business Report 2026: Capitalize on US$6 Billion Growth by 2032 as Abbott, Becton Dickinson, Bio-Rad, Danaher, and Sysmex Drive Automation

Life Science Instrumentation - Global Strategic Business Report 2026-2032 Featuring ACHB Enterprise, Agilent Technologies, BD, Bio-Rad Labs, Bruker Corp., ChromaCode, Danaher Corp., Emerson Electric Co., Eppendorf, GE Healthcare, Hitachi High-Tech Corp.

Life Science Instrumentation - Global Strategic Business Report 2026-2032 Featuring ACHB Enterprise, Agilent Technologies, BD, Bio-Rad Labs, Bruker Corp., ChromaCode, Danaher Corp., Emerson Electric Co., Eppendorf, GE Healthcare, Hitachi High-Tech Corp.

Glycomics / Glycobiology - Global Strategic Business Report 2026: Capitalize on a $4.5 Billion Market by 2032 | Agilent, Bruker, Danaher, Merck, and Thermo Fisher Battle for Share

Glycomics / Glycobiology - Global Strategic Business Report 2026: Capitalize on a $4.5 Billion Market by 2032 | Agilent, Bruker, Danaher, Merck, and Thermo Fisher Battle for Share

Mobilize your Website

View Site in Mobile | Classic

Share by: